跳至主要内容
临床试验/IRCT20220302054165N1
IRCT20220302054165N1已完成3 期

Efficacy and safety evaluation of modify maintenance instillation Bacillus- calmette-guerin (BCG) in , with stage Ta high grade and/or multiple and/or large and T1 bladder cancer

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with non-muscle invasive bladder cancer (stage Ta and T1).
  • Have a history of transurethral resection of tumor (TURT) one month before Bacillus-calmette-guerin (BCG) therapy.
  • Have no previous history of BCG instillation.
  • Do not have contraindications to BCG instillation.

排除标准

  • Patients with muscle invasive bladder cancer
  • Have a history of transurethral resection of tumor (TURT) more than one month before Bacillus-calmette-guerin (BCG) therapy.
  • Have previous history of BCG instillation.
  • Have contraindications to BCG instillation.

研究者

相似试验